Evidence map›Paper›PMID 42650694›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Nitrofurantoin Susceptibility and the Landscape of Multidrug-Resistant Gram-Negative Uropathogens in Kidney Transplant Recipients During the First Post-Transplant Year.

Aminah Alghamdi, Ehab Hammad, Fatimah S Alhamlan, Layla Alharbi, Reem Almaghrabi, Fatimah W Alsmail, Taghreed A Hafiz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aminah AlghamdiClinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.ORCID 0009-0001-0467-5975
Ehab HammadKidney and Pancreas Health Centre, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.ORCID 0000-0003-3321-2117
Fatimah S AlhamlanTranslational Research in Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.ORCID 0000-0003-1765-4310
Layla AlharbiTranslational Research in Infectious Diseases, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.ORCID 0000-0003-2695-2379
Reem AlmaghrabiKidney and Pancreas Health Centre, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
Fatimah W AlsmailKidney and Pancreas Health Centre, Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
Taghreed A HafizClinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.ORCID 0000-0001-8594-215X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

methodsIn a single-center retrospective cross-sectional study (KFSHRC, Riyadh; October 2024 to December 2025), 83 adult first-transplant recipients with a first-year Gram-negative UTI were included for analysis. Susceptibility was determined using VITEK 2/CLSI criteria, and MDR was defined according to Magiorakos/ECDC criteria.

resultsNitrofurantoin susceptibility varied significantly by species, with 89.2% in

conclusionsSpecies-directed therapy, such as nitrofurantoin for

Indexed as

antimicrobial resistanceantimicrobial stewardshipEscherichia colikidney transplantationKlebsiella pneumoniaemultidrug resistancePseudomonas aeruginosaurinary tract infection

Identifiers

PMID42650694
PMCPMC13510060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.